SGC-CAMKK2-1: A Chemical Probe for CAMKK2
- Cells. 2023 Jan 11;12(2):287. doi: 10.3390/cells12020287.
- 1. Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
- 2. Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
- 3. Centro de Química Medicinal (CQMED), Centro de Biologia Molecular e Engenharia Genética (CBMEG), Universidade Estadual de Campinas (UNICAMP), Campinas 13083-886, Brazil.
- 4. Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
- 5. St Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia.
- 6. Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, VIC 3052, Australia.
- 7. Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27705, USA.
- 8. Department of Medicine, Division of Hematological Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC 27710, USA.
- 9. Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.
- 10. The Florey Institute of Neuroscience and Mental Health, Parkville, VIC 3052, Australia.
- 11. Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- 12. Center for Nuclear Receptors and Cell Signaling, University of Houston, Houston, TX 77204, USA.
- 13. Department of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA.
- 14. Lineberger Comprehensive Cancer Center, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
The serine/threonine protein kinase calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) plays critical roles in a range of biological processes. Despite its importance, only a handful of inhibitors of CAMKK2 have been disclosed. Having a selective small molecule tool to interrogate this kinase will help demonstrate that CAMKK2 inhibition can be therapeutically beneficial. Herein, we disclose SGC-CAMKK2-1, a selective chemical probe that targets CAMKK2.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: CalmodulinResearch Areas: Cancer